Learn all about exquAIro

No matter how you look at it, AI will certainly change every aspect of our lives. The same holds for the pharmaceutical and medical field. How can we prepare for the future and how can we integrate AI skills in pharma and inside academia? With a hands-on approach, experts, a worldwide education network and education driven by fore-front research, exquAIro will make a difference in AI education for the pharmaceutical and medical field.

Why choose exquAIro?

Integrated AI skillset that improves and accelerates drug discovery & development 

Both AI and drug discovery & development thrive with cross-border collaboration across expertise domains. Having an integrated skillset is therefore essential. ExquAIro delivers skill building across four fundamental domains: Medical biology & Genetics, Impact & Leadership, Machine Learning & Statistics and Data & Technology. The broad curriculum (60+ coursed) is tailored to audiences within pharma throughout the drug development process2, from target discovery to clinical optimization.

Top-of-the-field expert faculty

ExquAIro is established, developed and taught by field experts from UMCG and AI professionals from Rewire. The UMCG is renowned for innovative research and healthcare and holds unique medical and biological knowledge. Rewire has a 15+ year track record in data and AI solutions and education for blue-chip companies, with a team of the best data scientists in the market. 

A proven worldwide education framework

ExquAIro employs the Global AI Network (GAIN®) learning method – a world standard in AI education that is used by companies like Nike, eBay and Heineken. All modules use the GAIN online learning environment to fully support the learning experience, with a Learning Management System (that contains all the training material and exercises), the AWS cloud workspace to do casework and an online proctored exam to test required skill levels. After passing the exam, participants receive and official, accredited certificate which can easily be added and shared on LinkedIn.

Hands-on approach on real-life cases 

Learning by doing takes center stage in all modules, which enables participants to master new AI skills and bridge theory to their own practice. In all trainings, theory is combined with practice on real-life cases from the pharma industry and medical field.  

Education driven by fore-front research 

The education content from exquAIro is based on AI research in the medical field. All profits of exquAIro are directly re-invested in novel research through the exquAIro foundation, that forms the basis for our educational material. This assures an education-research loop for continuous innovation and fore-front science. Hereby, participation in the program also contributes to society by funding medical research. This research also fuels our education with unique datasets, such as multi-omics, Whole Slide Images and longitudinal patient records.


The people behind exquAIro

Gerard Koppelman

Board member exquAIro | Professor in Pediatric Pulmonary Diseases at Universitair Medisch Centrum Groningen (UMCG)

One-person breakthroughs in science and medicine are very rare. Instead, I’m a big proponent of team and multidisciplinary science. Cross-border collaborations are as inspiring as they are productive. Bridging the gap between AI and pharma and medicine enables new innovations that were not possible previously. And on a more personal note: it is just incredibly fun and inspiring!

Martin Smit

Board member exquAIro | Director Graduate School of Medical Sciences UMCG and Program Manager Life Sciences at Healthy Ageing Network

As Director of the Graduate School of Medical Sciences, I am very happy that we can now also offer a post-graduate education program for professionals. This programs is tailored to boost continuous learning and developing within one’s career. Personally, I have more than 18 years of experience in drug discovery within the pharmaceutical industry. Within exquAIro, I am to provide those working in the drug discovery and development field, as well as medical researcher, with new AI tools to accelerate both their work and their personal development.

Marnix Bügel

Board member exquAIro | Founder Rewire

Medicine and pharma are driving forces of better health within our society. AI offers the opportunity to further accelerate this force. My aim with exquAIro is to enable professionals to realize breakthroughs in their field using AI. This is perfectly aligned with Rewire’s core values: creating breakthroughs, growth by learning and doing, and inspire on the future of AI. These values also take center stage within exquAIro.

Merlijn van Breugel

Board member exquAIro | Machine Learning lead at Rewire | PhD candidate at UMCG

Many people don’t know that the academic field of artificial intelligence was already born in 1955. However, it is only in the last decade that it has started to deliver on its promises. It has accelerated into a fast-growing field with novel application that were deemed impossible before. While many novel applications are not designed for the medical field per se, they can be of great value there. That’s also what drives me: finding impactful new applications of AI within the medical field.

Ilya Petoukhov

Founder of abeta.world: creating a better world using data

The promise of AI is to create amazing feats of technology that will enable many breakthroughs in the coming decades. For me, the most interesting applications are the ones where AI is used to ‘do good’. Within the medical and pharmaceutical field, this becomes very tangible in making humanity healthier. My personal ambition would be to empower people to use AI to improve treatments or find better drugs, faster. With over 10 years of experience in professional education, I’ve seen incredible ways in which people can grow and triple their value through learning. I am excited to ensure that the exquAIro curriculum delivers just what they need to grow and make the world healthier.

Martijn Nawijn

Editorial Board exquAIro | Associate Professor in functional genetics of chronic respiratory disease at Universitair Medisch Centrum Groningen (UMCG)

As a molecular geneticist and immunologist, I am interested in novel pathways regulating immune functions of airway epithelia. Recent advances in data technology have greatly boosted the available data sources and volumes, such single-cell RNA-seq data or FISH image data. However, analyzing this ultra high-dimensional data is challenging. Machine Learning and Deep Learning allow us to discover new patterns and pathways.

A collaboration to foster medical innovation with AI

Since 2018, UMCG and Rewire have worked together to perform fundamental research on the interface of AI and biomedicine. This has already resulted in 8 different research streams, demonstrating the value of cross-border collaboration firsthand. A key focus of this collaboration has been the use of multiple mixed data sources, to gain a better understanding of respiratory diseases. Through exquAIro, UMCG extends its already broad education for graduate studies, also to a postgraduate audience. The program builds on the data and AI expertise of Rewire and the educational framework of GAIN.


The University Medical Center Groningen (UMCG) is one of the largest hospitals in the Netherlands and the largest employer in the Northern Netherlands. The more than 12,000 employees work together on care, research, training and education with the common goal: building the future of health.


Rewire (previously MIcompany) is an Artificial Intelligence (AI) company with offices in Tel Aviv, Heidelberg and Amsterdam. From these offices, we drive AI transformations by building AI solutions and skills. Our team of more than 100 data scientists, AI engineers & software engineers serves industry-leading companies such as Nike, eBay, Booking.com, Heineken, KPN, Lease Plan, Aegon and Shufersal. In more than 25 countries.


The Global Artificial Intelligence Network (GAIN®) is an initiative of Rewire that offers a worldwide open standard portfolio in AI skill building for individuals and businesses through a members’ network. GAIN aims to build and certify all skills within organizations to radically change key processes and increase productivity using AI. The scalable and modular training portfolio consist of more than 60 courses and certifications, and is designed by industry experts with 15+ years of experience.

AI Chalk Talk video on the DNA research of UMCG & Rewire